A serious safety alert has been issued for a serum after tests revealed dangerous levels of a prohibited chemical substance.

Scalp psoriasis is a common autoimmune condition. It causes raised, discoloured patches on the scalp, leading to itchiness ...

Chardan is acting as sole placement agent for the offering.

Taiwan-based Formosa Pharmaceuticals (6838: TW) revealed that it has entered into an exclusive licensing agreement with Medvisis Switzerland, in Switzerland and Liechtenstein, for exclusive rights to ...

In what the HSA described in a Nov 27 statement as a “first-of-its-kind large-scale collaboration with online platform ...

The eight platforms are Amazon Singapore, Carousell, eBay Singapore, Facebook, Lazada, Qoo10, Shopee and TikTok.

This positive outlook could be related to Eyenovia's plans to further develop its Optejet device and commercialize products like Mydcombi and clobetasol propionate. However, it's important to note ...

The analyst pointed out that while Eyenovia's pipeline and commercial products, including the newly launched clobetasol propionate ophthalmic solution 0.05%, hold value, the company's capital ...

Additional details will be shared after the evaluation is complete. The company currently has two FDA-approved products, Mydcombi and clobetasol propionate, which are indicated for in-office pupil ...

The notification introduces SION No. A-3682, which pertains to the export product clobetasol propionate, a key pharmaceutical compound, under the Chemical and Allied Product group (Product Code 'A').

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension ... estimated market opportunities for our product candidates and platform technology, the ...

Eyenovia has two marketed products, including clobetasol propionate 0.05% eye drops, approved in March 2024 to treat post-operative inflammation and pain after eye surgery. Developed with Taiwan-based ...